Wei-Wen Lin
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications 11
- Genetics top 5%
- Mesenchymal stem cell research 6
- Surgery top 10%
- Tissue Engineering and Regenerative Medicine 11
- Cardiac Structural Anomalies and Repair 5
- Lipoproteins and Cardiovascular Health 3
- Urology top 10%
-
- Eosinophilic Disorders and Syndromes 2
-
- MicroRNA in disease regulation 2
-
- Cardiovascular Effects of Exercise 2
- Co-authors
- Hsing‐Wen SungYen ChangShiaw‐Min HwangHao‐Ji WeiWen-Yu LeeChun‐Hung ChenYi‐Chun YehChung‐Chi Wang
- Cited by
- BiomaterialsGeneticsSurgery
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wei-Wen Lin
25 papers receiving 707 citations
Peers
Comparison fields: 5 of 78
- Biomaterials 353
- Genetics 248
- Surgery 453
- Urology 38
- Molecular Medicine 23
Countries citing papers authored by Wei-Wen Lin
This map shows the geographic impact of Wei-Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Wen Lin more than expected).
Fields of papers citing papers by Wei-Wen Lin
This network shows the impact of papers produced by Wei-Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Wen Lin. The network helps show where Wei-Wen Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei-Wen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 6 | |
| 8 | 2021 | 1 | |
| 9 | 2015 | 1 | |
| 10 | 2013 | 32 | |
| 11 | 2012 | 61 | |
| 12 | 2012 | 1 | |
| 13 | 2011 | 26 | |
| 14 | 2009 | 10 | |
| 15 | 2008 | 38 | |
| 16 | 2008 | 3 | |
| 17 | 2007 | 0 | |
| 18 | 2007 | 56 | |
| 19 | 2007 | 26 | |
| 20 | 2007 | 81 |
About Wei-Wen Lin
Wei-Wen Lin is a scholar working on Biomaterials, Genetics and Surgery, having authored 27 papers that have together received 721 indexed citations. Recurring topics across this work include Tissue Engineering and Regenerative Medicine (11 papers), Electrospun Nanofibers in Biomedical Applications (11 papers), Mesenchymal stem cell research (6 papers), Cardiac Structural Anomalies and Repair (5 papers), Lipoproteins and Cardiovascular Health (3 papers), Eosinophilic Disorders and Syndromes (2 papers), MicroRNA in disease regulation (2 papers) and Cardiovascular Effects of Exercise (2 papers). The work is most often cited by research in Biomaterials (353 citations), Genetics (248 citations) and Surgery (453 citations). Wei-Wen Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Hsing‐Wen Sung, Yen Chang, Shiaw‐Min Hwang, Hao‐Ji Wei, Wen-Yu Lee, Chun‐Hung Chen, Yi‐Chun Yeh, Chung‐Chi Wang, Chieh‐Cheng Huang and Po-Hong Lai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.